VIVUS VVUS Stock News

VIVUS, Inc. (NASDAQ: VVUS) is running for the top in the market this morning, with gains that are better stated in multiples than percentages. The gains come after the company announced the launch of a product to assist with social distance in medicine. Here’s what’s happening:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

VVUS Accelerates Telemedicine Launch

In the press release, VIVUS said that it is accelerating the launch of the telemedicine and remote monitoring modules of its Health Platform. This will give participating physicians the ability to use the VIVUS Health Platform to conduct virtual office visits. Importantly, this service will be enabled for patients regardless of if they are prescribed a VVUS product or not.

It is expected that the company will enroll between 150 and 200 physicians into the new module each week.

In a statement, John Amos, CEO at VVUS, had the following to offer:

Effective communication around health conditions, such as obesity, can be difficult under the best of circumstances, and are even more challenging in the current environment in which patients, physicians, and care facilities are adhering to social distancing guidelines to prevent the spread of COVID-19. These guidelines also make it difficult for cystic fibrosis patients, who are at increased risk of COVID-19 due to their compromised lung function, to consult with their healthcare providers. We have rapidly accelerated the launch of our telemedicine and remote monitoring modules to facilitate communication during this unprecedented pandemic and ensure that patients can receive optimum care without leaving their homes.

Why This Is Such A Big Announcement

As we all know, Covid-19 is changing the shape of life as we know it. When was the last time you couldn’t find a single loaf of bread, roll of toilet paper, or bottle of bleach on the shelves of your local Walmart? I know that I’ve never seen anything like this.

As the coronavirus spreads, social distance is key. Medical professionals, governments, and other parties are essentially begging consumers to stay home and away from the general public. That’s where VIVUS comes in.

The truth of the matter is those at most risk these days are the physicians who have contact with COVID-19 patients. Considering the fact that VVUS is providing a product that gives physicians the opportunity to see patients indirectly, there’s a strong chance that demand will be high here.

All in all, this is a huge revenue opportunity and just as big of an opportunity for VVUS investors.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Don’t Miss The Next Big Story

Join our free mailing list below to receive real-time news alerts!

Subscribe Today!

* indicates required


LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.